Affordable Access

Oral contraceptives and breast cancer risk in Denmark.

Authors
  • Ewertz, M1
  • 1 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen.
Type
Published Article
Journal
European Journal of Cancer
Publisher
Elsevier
Publication Date
Jan 01, 1992
Volume
28A
Issue
6-7
Pages
1176–1181
Identifiers
PMID: 1627391
Source
Medline
License
Unknown

Abstract

To evaluate the influence of oral contraceptives (OCs) on breast cancer risk, a population-based case-control study was conducted in Denmark. The study population included women aged less than 40 years (203 cases, diagnosed between 1 March 1983 and 31 August 1984, and 212 controls) and women aged 40-59 years (856 cases, diagnosed between 1 March 1983 and 29 February 1984, and 779 controls). Cases were identified from the nationwide clinical trial of the Danish Breast Co-operative Group and the Danish Cancer Registry. The control groups were age-stratified random samples of the general female population. Data on OC use and breast cancer risk factors were collected by self-administered questionnaires. In both age groups, no significant association was detected between breast cancer risk and duration, age at start, latency or recency of OC use. However, the data provided some limited support that OCs containing 50 micrograms or more oestrogen may be more harmful than pills with a lower oestrogen dose.

Report this publication

Statistics

Seen <100 times